UiPath Inc. shares edged higher on Tuesday, gaining approximately 2.7% to trade at $11.22 in midday New York trading. The uptick came as U.S. markets reopened after the Memorial Day holiday, with traders positioning themselves ahead of the company's fiscal first-quarter earnings report, scheduled for release after the closing bell on Thursday, May 28.
The stock moved within a range of $10.74 and $11.40, with trading volume reaching nearly 31.9 million shares. For context, the QQQ ETF, which tracks major technology stocks, added around 1.5% on the day, reflecting a broader positive sentiment in the tech sector.
UiPath's management has guided for quarterly revenue between $395 million and $400 million for the April quarter, with annualized recurring revenue (ARR) expected to land in the range of $1.894 billion to $1.899 billion. ARR represents the annualized value of subscription and support contracts from existing customers, and it is a key metric that investors will scrutinize closely.
The company's fiscal 2026 results showed ARR of $1.853 billion, an 11% year-over-year increase, while quarterly revenue reached $481 million, up 14%. UiPath also reported GAAP operating income of $80 million for the quarter and $57 million for the full fiscal year, marking a milestone of full-year GAAP profitability, as highlighted by COO and CFO Ashim Gupta.
CEO Daniel Dines has emphasized that enterprise AI is moving beyond pilot programs into broader deployments, with customers demanding "reliability, governance, and scale." UiPath's strategic focus is on "agentic automation," which combines AI agents with robotic process automation to handle complex business tasks, while humans retain oversight for high-risk decisions.
However, the company faces stiff competition from tech giants like Microsoft and ServiceNow, which are also targeting similar enterprise budgets. Analysts have expressed caution; Oppenheimer maintained a Perform rating, citing slower growth and competitive pressures, while UBS lowered its price target to $13 with a Neutral stance. On the latest earnings call, analysts from Wells Fargo and Morgan Stanley questioned management about competition and ARR contributions from AI products.
Any disappointment in ARR growth, weaker customer expansion, or cautious commentary on large enterprise deals could trigger a sharp sell-off. UiPath's own annual filing warns of intense competition from established players and new entrants as a key risk factor. Additionally, the company's dual-class share structure and concentrated voting control may dampen demand for its Class A shares.
Share buybacks have provided some support. UiPath completed a $1 billion buyback program and announced a new $500 million authorization in March. The company will determine the pace of repurchases based on market conditions and alternative uses of cash.
Tuesday's price action appears to reflect investors positioning ahead of earnings rather than a definitive directional bet. The true test will come on Thursday evening, when the market receives fresh data on fiscal 2027 demand, AI momentum, and whether UiPath's margins can continue to improve as growth remains uncertain.
